Lineage Cell Therapeutics, Inc.·5

Feb 14, 4:16 PM ET

KINGSLEY ALFRED D 5

5 · Lineage Cell Therapeutics, Inc. · Filed Feb 14, 2023

Insider Transaction Report

Form 5
Period: 2022-12-31
Transactions
  • Gift

    Common Shares, no par value

    2022-12-0125,0005,430,545 total
Holdings
  • Common Shares, no par value

    (indirect: By Corporation)
    1,043,346
  • Common Shares, no par value

    (indirect: By LP)
    375,351
Footnotes (3)
  • [F1]Represents a gift of 25,000 common shares.
  • [F2]Held by Greenbelt Corporation, of which Mr. Kingsley is an executive officer, director, and controlling shareholder. Mr. Kingsley disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest.
  • [F3]Held by Greenway Partners, LP, of which Mr. Kingsley is the General Partner and has sole voting and dispositive control.

Documents

1 file
  • 5
    ownership.xmlPrimary